Effect of cilostazol on optimized standard antiplatelet therapy in a patient with a cytochrome P450 2C19 *2/*2 genotype

Cardiovascular Intervention and Therapeutics

Volumn 26, Issue 1, 2011, Pages 79-82

  Fu, Qiang ^a   Suzuki, Nobuaki ^a   Takada, Kaoru ^a   Yamamoto, Hirosada ^a   Ishikawa, Shuichi ^a   Yokoyama, Naoyuki ^a   Kozuma, Ken ^a   Isshiki, Takaaki ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute coronary syndrome; Antiplatelet therapy; Coronary intervention; Stent thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; CILOSTAZOL; CLOPIDOGREL; CREATINE KINASE; CYTOCHROME P450 2C19; DUAL SPECIFICITY PHOSPHATASE 2; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PADGEM PROTEIN; TROPONIN I; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BARE METAL STENT; BLOOD CLOTTING PARAMETERS; BRAIN INFARCTION; CANNABIS SMOKING; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY BLOOD FLOW; CREATINE KINASE BLOOD LEVEL; DIABETES MELLITUS; ELECTROCARDIOGRAM; EMERGENCY WARD; FIBRIN CLOT; FLOW CYTOMETRY; FOLLOW UP; GENOTYPE; HEART ARREST; HEART INFARCTION; HUMAN; HYPERTENSION; INTRAVASCULAR ULTRASOUND; LOADING DRUG DOSE; MALE; OPTICAL COHERENCE TOMOGRAPHY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RESUSCITATION; RIGHT CORONARY ARTERY; ST SEGMENT DEPRESSION; STENT THROMBOSIS; TACHYCARDIA; THORAX PAIN; THROMBOCYTE AGGREGATION;

EID: 84862976077     PISSN: 18684300     EISSN: 18684297     Source Type: Journal    
DOI: 10.1007/s12928-010-0036-x     Document Type: Article

References (13)

1. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet. 2001; 358: 527-33.
2. Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol. 2007; 49: 1505-16.
3. Buonamici P, Marcucci R, Migliorini A, Gensini GF, Santini A, Paniccia R, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol. 2007; 49: 2312-7.
4. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005; 293: 2126-30.
5. Lemesle G, Delhaye C, Bonello L, de Labriolle A, Waksman R, Pichard A. Stent thrombosis in 2008: definition, predictors, prognosis and treatment. Arch Cardiovasc Dis. 2008; 101: 769-77.
6. Liu X, Doi H, Maehara A, Mintz GS, de Costa RJ Jr, Sano K, et al. A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis. JACC Cardiovasc Interv. 2009; 2: 428-34.
7. Matetzky S, Shenkman B, Guetta V, Shechter M, Bienart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004; 109: 3171-5.
8. Simon T, Verstuyft C, Mary-Krause M, Quteineh L, Drouet E, Méneveau N, et al. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med. 2009; 360: 363-75.
9. Mega JL, Close SL, Wiviott SD, Shen L, Hockett RD, Brandt JT, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009; 360: 354-62.
10. Jinnai T, Horiuchi H, Makiyama T, Tazaki J, Tada T, Akao M, et al. Impact of CYP2C19 polymorphisms on the antiplatelet effect of clopidogrel in an actual clinical setting in Japan. Circ J. 2009; 73: 1498-503.
11. Mehta SR, et al. CURRENT OASIS 7: a 2 × 2 factorial randomized trial of optimal clopidogrel and aspirin dosing in patients with ACS undergoing an early invasive strategy with intent for PCI. In: 2009 Congress European Society of Cardiology; 30 August 2009, Spain.
12. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357: 2001-15.
13. Lee SW, Park SW, Hong MK, Kim YH, Lee BK, Song JM, et al. Triple versus dual antiplatelet therapy after coronary stenting: impact on stent thrombosis. J Am Coll Cardiol. 2005; 46: 1833-7.